COMP <GO>
ZBH vs STE // EV/EBITDA & P/E VALUATION
Zimmer Biomet Holdings Inc. (NYSE) VS. STERIS plc (Ireland) (NYSE) • 15-METRIC TALLY: ZBH 3
— STE 11
▲ EV/EBITDA & P/E VALUATION LEADER: STE
LAST: $94.52 (-3.03%) • MKT CAP: $18.59B
valuation
19.3x
LAST: $227.12 (-2.16%) • MKT CAP: $22.63B
valuation
17.0x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZBH VS. STE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ZBH | STE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 69.70% | 44.20% | +25.50 | ZBH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.60% | 10.10% | -5.50 | STE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 19.3x | 17.0x | +2.30 | STE | /valuation <GO> |
| Free Cash Flow Yield | 7.92% | 4.30% | +3.62 | ZBH | /fcf-yield <GO> |
| Operating Margin | 13.30% | 18.60% | -5.30 | STE | /operating-margins <GO> |
| Net Profit Margin | 8.60% | 13.20% | -4.60 | STE | /net-margins <GO> |
| Revenue Growth (YoY) | 7.20% | 8.70% | -1.50 | STE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.02% | 1.07% | -0.05 | STE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.42 | 5.40 | -2.98 | STE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 9/9 | -1.00 | STE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.0 | 62.4 | -5.40 | STE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | 1.08 | -0.06 | STE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 24.6x | 26.9x | -2.30 | ZBH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $18.59B | $22.63B | -$4.04B | STE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ZBH REV | STE REV | ZBH GROSS % | STE GROSS % | ZBH FCF | STE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $8.23B | $5.94B | 69.7% | 44.2% | $1.47B | $972.4M |
| FY 2024 | $7.68B | $5.46B | 71.5% | — | $1.30B | $778.0M |
| FY 2023 | $7.39B | $5.14B | — | — | $1.25B | $742.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZBH // BETA 1.02
STE // BETA 1.08